LENZ

LENZ Therapeutics

58 hedge funds and large institutions have $432M invested in LENZ Therapeutics in 2021 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 25 increasing their positions, 11 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding in top 10

Funds holding in top 10:

less ownership

Funds ownership:

less funds holding

Funds holding:

18% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 11

27% less capital invested

Capital invested by funds: $587M → $432M (-$156M)

Holders
58
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$8.56M
2 +$5.22M
3 +$3.54M
4
BlackRock
BlackRock
New York
+$3.26M
5
SFM
Sphera Funds Management
Israel
+$1.64M

Top Sellers

1 -$15.2M
2 -$14.9M
3 -$9.94M
4
Millennium Management
Millennium Management
New York
-$5.15M
5
Jennison Associates
Jennison Associates
New York
-$4.86M
Name Holding Trade Value Shares
Change
Change in
Stake
51
$45K
52
$39K
53
$19K
54
$16K
55
$15K
56
$3.36K
57
$2.49K
58
$2K
59
60
61
62
63
64
65
66
67
68
69